Following the failure of hotly debated prescription drug legislation in Maryland, one closely involved lobbyist says his side will be ready for a renewed fight in 2015.“We will probably take a harder line next year,” Jack Andryszak, a lobbyist for insurers in the state, said in an interview Tuesday.Andryszak worked to support House Bill 280, which was supported by insurers and employers. The measure would have placed a 30-day limit on the authority of physicians to receive reimbursement for prescription medicine dispensed to claimants. The state’s Medical Society opposed the ...
Comments